Japan Sports Agency and JADA Host Online “2020 International Seminar” in Partnership with WADA

TOKYO, Dec. 4, 2020 /PRNewswire/ — The Japan Sports Agency (JSA) of the Japanese Government and the Japan Anti-Doping Agency (JADA) hosted the annual “International Anti-Doping Seminar in Asia & Oceania” on December 1-3. The 14th annual seminar was organized as “GoVirtual” for the first time due to COVID-19. 2020 is a landmark year for anti-doping organizations (ADOs) as the revised World Anti-Doping Code (2021Code) and International Standards will become effective from January 2021. The seminar in this significant timing has brought together more than 200 people from 52 countries/regions online to exchange information matching the needs of ADOs, and the participants virtually united despite the time difference.

Images: https://kyodonewsprwire.jp/release/202012038062?p=images

The theme of the 2020 seminar was “Are you ready!?–for the 2021Code & International Standards and for beyond.” JADA developed the agenda with WADA based on the input from the anti-doping community in Asia and Oceania in

Read More

Sidewalk chosen to host Sundance Film Festival as a satelite site

Sidewalk welcomes Sundance Film Festival
Sidewalk Cinema at the Pizitz. Photo by Matthew Niblett

This is a match made in heaven and a big coup for the Magic City.

Sidewalk Film Center + Cinema and the Sidewalk Film Festival announced yesterday that they have been selected to host the 2021 Sundance Film Festival as a satelite location. Birmingham will be one of only thirty locations nationwide partnering with the prestigious  festival. 

Sundance to Sidewalk

Birmingham, Sidewalk Film Festival
Don’t worry, concessions will still be available for your movie snack. Photo via Matthew Niblett for Bham Now

Here is Sidewalk’s statement about the partnership and what to expect in 2021.

“Sidewalk is thrilled to have been selected as one of only 30 sites across the country to partner with Sundance, a leader in the independent film industry for over 40 years, for their unique 2021 Festival. Our organization has a

Read More

Venus Concept to Host Virtual “Aesthetic & Hair Restoration Technology” Event on December 10th

TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that the Company will host a virtual Aesthetic & Hair Restoration Technology event on Thursday, December 10, 2020. The live webcast of the event will begin at 10:00 a.m. ET and conclude at approximately 12:00 p.m. ET.

During the event, Venus Concept will feature discussions and demonstrations of key technologies driving growth in the global aesthetic and hair restoration markets, including the Company’s current noninvasive fat and body contouring platform, the Venus Bliss, IOT data functionality and recent advancements in the ARTAS® and ARTAS iX® Robotic Hair Restoration Systems.

Venus Concept will also discuss the future of robotic technologies in aesthetic medicine, including a preview of the Company’s initial robotic technology for aesthetic medicine, the Venus RoboCor, which is designed for minimally

Read More

Legend Biotech to Host Virtual Investor KOL Event Reviewing Latest CARTITUDE-1 Data from the 62nd American Society of Hematology (ASH) Annual Meeting

SOMERSET, N.J.–(BUSINESS WIRE)–Nov 24, 2020–

Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech) today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, December 7 at 7 pm ET highlighting the latest data from the Phase 1b/2 CARTITUDE-1 study ( NCT03548207 ) of ciltacabtagene autoleucel (cilta-cel), an investigational BCMA-directed CAR-T cell therapy being studied for the treatment of patients with relapsed or refractory multiple myeloma. This will follow the oral presentation of the study results ( Abstract #177 ) at the 2020 ASH Annual Meeting.

Intended for investors and other interested audiences, the event includes presentations by Ying Huang, PhD, CEO and CFO of Legend Biotech, along with the following leading professionals in hematology and oncology:

  • Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine; Director, Multiple Myeloma Program at Mount Sinai Hospital.
  • Thomas G. Martin, MD, Clinical Professor of
Read More

Legend Biotech to Host Virtual Investor KOL Event Reviewing Latest CARTITUDE-1 Data from the 62nd American Society of Hematology (ASH) Annual Meeting – Press Release

SOMERSET, N.J.–(Business Wire)–Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech) today announced that it will host a virtual Key Opinion Leader (KOL) event on Monday, December 7 at 7 pm ET highlighting the latest data from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) of ciltacabtagene autoleucel (cilta-cel), an investigational BCMA-directed CAR-T cell therapy being studied for the treatment of patients with relapsed or refractory multiple myeloma. This will follow the oral presentation of the study results (Abstract #177) at the 2020 ASH Annual Meeting.

Intended for investors and other interested audiences, the event includes presentations by Ying Huang, PhD, CEO and CFO of Legend Biotech, along with the following leading professionals in hematology and oncology:

  • Sundar Jagannath, MD, Professor of Medicine, Hematology and Medical Oncology, Mount Sinai School of Medicine; Director, Multiple Myeloma Program at Mount Sinai Hospital.
  • Thomas G. Martin, MD, Clinical Professor of Medicine, Adult Leukemia and Bone Marrow Transplantation
Read More

Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer

SOUTH SAN FRANCISCO, Calif., Nov. 24, 2020 /PRNewswire/ — Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics,  announced today that it will host a live webcast event to provide a clinical update from the company’s ongoing dose escalation Phase 1 study of STRO-002, a folate receptor alpha (FolRα) targeting antibody-drug conjugate (ADC), for patients with ovarian cancer. The results presented will follow-up on previously presented data, based on a new data cut-off date of Oct. 30, 2020. The company will also give an update on the program expansion cohorts in ovarian and endometrial cancer. The virtual KOL Discussion of STRO-002 Data will be held on Thursday, Dec. 3, 2020, at 5pm ET / 2pm PT.

The data will be presented and discussed by

Read More

The drug aprotinin inhibits entry of SARS-CoV2 in host cells, study finds — ScienceDaily

In order for the SARS-CoV2 virus to enter host cells, its “spike” protein has to be cleaved by the cell’s own enzymes — proteases. The protease inhibitor aprotinin can prevent cell infection, as scientists at Goethe University, the University of Kent and the Hannover Medical School have now discovered. An aprotinin aerosol is already approved in Russia for the treatment of influenza and could readily be tested for the treatment of COVID-19.

The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell. Before this docking is possible, parts of the spike protein have to be cleaved by the host cell’s enzymes — proteases.

In cell culture experiments with various cell types, the international scientific team led by Professor Jindrich Cinatl, Institute for Medical Virology at the University Hospital Frankfurt, Professor

Read More

EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug …

WATERTOWN, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced it will host a key opinion leader roundtable discussion on the future of local drug delivery for wet aged-related macular degeneration (AMD) and an overview of EYP-1901, the Company’s potential six-month sustained delivery intravitreal anti-VEGF therapy for wet AMD. The event will take place virtually on Friday, December 4, 2020, at 12:00 p.m. ET.

Scheduled to participate in the event are several leading retina specialists, including Robert Avery, M.D., Founder and Chief Executive Officer, California Retina Consultants; Elias Reichel, M.D., Professor and Vice Chair, Director, Vitreoretinal Service, New England Eye Center, Tufts University of Medicine; and Charles Wykoff, M.D., Ph.D., Director of Research, Retina Consultants of Houston, Deputy Chair For Ophthalmology, Blanton Eye Institute.

To access the event, please dial (877) 870-4263 from the

Read More

HKTDC to Host Five Major Annual Events in Early December

The MarketWatch News Department was not involved in the creation of this content.

Nov 18, 2020 HONG KONG, Nov 19, 2020 (JCN Newswire via COMTEX) —
The Hong Kong Trade Development Council (HKTDC) is staging five industry-leading events online in early December, namely the HKTDC SmartBiz Expo, HKTDC Hong Kong International Franchising Show, the Business of IP Asia Forum (BIP Asia Forum), DesignInspire, and the Asian E-tailing Summit. Through these brand-new online platforms, numerous industry elite speakers will look at the current business practices of small and medium-sized enterprises (SMEs) and examine how they can apply innovative technologies and creative thinking to address the challenges of an evolving market landscape, and to help strengthen their development during the pandemic and beyond.

HKTDC Assistant Executive Director Stephen Liang said: “In light of the global pandemic, several HKTDC events are going online, but this doesn’t impede our efforts to provide the latest

Read More

Verb Technology Co., Inc. to Host Earnings Call

The MarketWatch News Department was not involved in the creation of this content.

November 16, 2020 (ACCESSWIRE via COMTEX) —
NEW YORK, NY / ACCESSWIRE / November 16, 2020 / Verb Technology Co., Inc. (NASDAQ:VERB) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 16, 2020 at 5:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/event/presentation/71593

To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand,

Read More